Universal Biosensors Inc Cash Flow Conversion Efficiency

Latest as of June 2025: -0.301x

Universal Biosensors Inc cash flow conversion efficiency. Based on the latest financial reports, Universal Biosensors Inc (UBI) has a cash flow conversion efficiency ratio of -0.301x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-2.13 Million ≈ $-1.51 Million USD) by net assets (AU$7.08 Million ≈ $5.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Universal Biosensors Inc (2002–2024)

Cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024. This chart illustrates how Universal Biosensors Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View UBI live share price for real-time trading data and today's change.

Universal Biosensors Inc Cash Flow Conversion Ratio Explained

Universal Biosensors Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Universal Biosensors Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Universal Biosensors Inc ranked by their cash flow conversion efficiency. Also see UBI market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Clara Resources Australia Ltd
AU:C7A
-0.096x
International Lithium Corp
V:ILC
-0.028x
MacDonald Mines Exploration Ltd
V:BMK
-0.004x
Golden Ridge Resources Ltd
V:GLDN
-0.019x
Colabor Group Inc.
TO:GCL
0.101x
P/F Atlantic Petroleum
CO:ATLA-DKK
0.006x
ARGO GOLD INC.
F:P3U
0.038x
Cullen Resources Ltd
AU:CUL
0.183x

Annual Cash Flow Conversion Efficiency for Universal Biosensors Inc (2002–2024)

The table below shows the annual cash flow conversion efficiency of Universal Biosensors Inc from 2002 to 2024. Review UBI FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$17.37 Million
≈ $12.29 Million
AU$-12.30 Million
≈ $-8.70 Million
-0.708x +5.51%
2023-12-31 AU$19.51 Million
≈ $13.80 Million
AU$-14.62 Million
≈ $-10.34 Million
-0.749x -32.99%
2022-12-31 AU$26.09 Million
≈ $18.46 Million
AU$-14.70 Million
≈ $-10.40 Million
-0.563x -57.19%
2021-12-31 AU$27.61 Million
≈ $19.53 Million
AU$-9.90 Million
≈ $-7.00 Million
-0.358x -64.20%
2020-12-31 AU$37.98 Million
≈ $26.87 Million
AU$-8.29 Million
≈ $-5.87 Million
-0.218x -129.81%
2019-12-31 AU$45.39 Million
≈ $32.12 Million
AU$33.24 Million
≈ $23.52 Million
0.732x +2003.00%
2018-12-31 AU$50.67 Million
≈ $35.85 Million
AU$1.76 Million
≈ $1.25 Million
0.035x -94.88%
2017-12-31 AU$12.77 Million
≈ $9.04 Million
AU$8.69 Million
≈ $6.15 Million
0.681x +27.96%
2016-12-31 AU$13.25 Million
≈ $9.38 Million
AU$7.05 Million
≈ $4.99 Million
0.532x +285.32%
2015-12-31 AU$13.26 Million
≈ $9.38 Million
AU$1.83 Million
≈ $1.29 Million
0.138x +150.33%
2014-12-31 AU$19.74 Million
≈ $13.97 Million
AU$-5.41 Million
≈ $-3.83 Million
-0.274x +51.04%
2013-12-31 AU$29.68 Million
≈ $21.00 Million
AU$-16.63 Million
≈ $-11.77 Million
-0.560x -568.20%
2012-12-31 AU$39.37 Million
≈ $27.86 Million
AU$-3.30 Million
≈ $-2.34 Million
-0.084x +58.99%
2011-12-31 AU$35.02 Million
≈ $24.78 Million
AU$-7.16 Million
≈ $-5.07 Million
-0.204x -50.48%
2010-12-31 AU$47.22 Million
≈ $33.41 Million
AU$-6.41 Million
≈ $-4.54 Million
-0.136x -218.81%
2009-12-31 AU$51.31 Million
≈ $36.31 Million
AU$5.87 Million
≈ $4.15 Million
0.114x +177.99%
2008-12-31 AU$48.70 Million
≈ $34.46 Million
AU$-7.14 Million
≈ $-5.05 Million
-0.147x +5.45%
2007-12-31 AU$60.07 Million
≈ $42.51 Million
AU$-9.31 Million
≈ $-6.59 Million
-0.155x -146.03%
2006-12-31 AU$37.05 Million
≈ $26.21 Million
AU$-2.33 Million
≈ $-1.65 Million
-0.063x -209.68%
2005-12-31 AU$3.93 Million
≈ $2.78 Million
AU$226.00K
≈ $159.91K
0.057x +11.37%
2004-12-31 AU$3.97 Million
≈ $2.81 Million
AU$205.00K
≈ $145.05K
0.052x -79.48%
2002-12-31 AU$1.36 Million
≈ $962.29K
AU$342.00K
≈ $241.99K
0.251x --

About Universal Biosensors Inc

AU:UBI Australia Medical Devices
Market Cap
$2.95 Million
AU$4.17 Million AUD
Market Cap Rank
#29469 Global
#1648 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.01
All Time High
AU$1.00
About

Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of… Read more